Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Feb 11, 2022 · 10-K · 42 days after period end · 0000012208-22-000011
| Metric | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $732.72M | $789.81M | $624.47M | $616.83M |
| Net Income | -$1.57B | $839.20M | $553.50M | -$828.50M |
| EPS Diluted | -$52.54 | $27.81 | $18.31 | -$27.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 11, 2022 · 42 d after period end
